Concepedia

Takuya Suzuki

TS

Statistics

Publications

40

Citations

2.5K

H-Index

25

Active since

1971

Affiliations

Eisai (Japan)(Current)

National Cancer Center Hospital East

Eisai (United States)

Kobe University Hospital

Tokushima University

Takuya Suzuki is an author at Eisai (Japan) specializing in medicine, oncology, and pharmacology.

ORCID

Top concepts

Publications per year

1971–2022

40

Publications

40

Phase 2 study of lenvatinib in patients with advanced hepatocellular carcinoma

Kenji Ikeda, Masatoshi Kudo, Seiji Kawazoe et al. · Journal of Gastroenterology · 2016 · 342 citations · Full text

PEG shedding-rate-dependent blood clearance of PEGylated lipid nanoparticles in mice: Faster PEG shedding attenuates anti-PEG IgM production

Takuya Suzuki, Yuta Suzuki, Taro Hihara et al. · International Journal of Pharmaceutics · 2020 · 193 citations

, , +6

Lenvatinib for Anaplastic Thyroid Cancer

Makoto Tahara, Naomi Kiyota, Tomoko Yamazaki et al. · Frontiers in Oncology · 2017 · 188 citations · Full text

Safety and Pharmacokinetics of Lenvatinib in Patients with Advanced Hepatocellular Carcinoma

Masafumi Ikeda, Takuji Okusaka, Shuichi Mitsunaga et al. · Clinical Cancer Research · 2015 · 184 citations

A Phase II Study of the Safety and Efficacy of Lenvatinib in Patients with Advanced Thyroid Cancer

Shunji Takahashi, Naomi Kiyota, Tomoko Yamazaki et al. · Future Oncology · 2019 · 137 citations · Full text

1–5 of 40